Biden wants Medicare, Medicaid to cover pricey weight loss drugs such as Wegovy
The Biden administration wants to expand coverage of anti-obesity medications to millions on Medicare, Medicaid.
Biden administration adds weight-loss drugs to Medicare
While recent advances in medicine have created prescription anti-obesity GLP-1 medications — like Ozempic, Wegovy, and Mounjaro — accessibility to these drugs is limited. The average prescription costs $1,
Medicare proposes covering weight-loss drugs, teeing up clash with RFK Jr.
The proposal would expand coverage of anti-obesity drugs to 7.5 million people covered by Medicare and Medicaid, the Biden administration said.
Biden to require Medicare and Medicaid to cover weight loss drugs
President Biden plans to roll out a new plan that would require coverage of weight loss drugs for patients of Medicare and Medicaid. The move could potentially help some seven million Americans pay for the expensive drugs,
Who gets weight loss drugs covered by insurance? In North Carolina, being on Medicaid helps.
North Carolina stopped covering weight loss drugs such as Ozempic for state employees without diabetes. But it extended coverage for Medicaid recipients.
Biden proposes Medicare and Medicaid cover costly weight-loss drugs for millions of obese Americans
Millions of Americans would be eligible to have costly weight-loss drugs like Wegovy or Ozempic covered by Medicare or Medicaid under the rule.
Biden Administration Proposes Covering Obesity Drugs In Medicare And Medicaid
It's uncertain whether the Biden administration proposal to cover obesity drugs in Medicare and Medicaid will survive decisions made by the incoming Trump administration.
Biden Says Medicare, Medicaid Should Cover Obesity Drugs—What Could That Mean for Access?
Fact checked by Nick Blackmer The Biden Administration proposed a new rule that would require Medicare and Medicaid to cover some anti-obesity medications for people who are obese, beginning in 2026.More than 40% of Americans have obesity,
Why your copay for weight loss drugs like Wegovy just went through the roof
Even as weight-loss drugs such as Wegovy and Zepbound explode in popularity, many Americans struggle to afford them.
Why the New Weight Loss Drugs Don't Work for Some People
Clinical trials have shown that people using weight-loss jabs, such as Wegovy and Mounjaro, lose anywhere between 16% and 21% ...
Thanksgiving may feel different for Americans on weight loss drugs. Here's why.
This may be the first Thanksgiving for millions of Americans who are on GLP-1 agonists like Ozempic, Zepbound or Wegovy.
West Virginia MetroNews19h
West Virginia leaders embrace effects of weight loss drugs, while also considering cost
The outgoing Biden administration is proposing to have popular weight-loss drugs like Wegovy or Zepbound covered by Medicare ...
Scientists Uncover New Cardiovascular Benefits of Popular Weight Loss Drugs
New studies in JACC highlight improvements in cardiac structure and function among CABG patients, as well as changes in ...
The Durango Herald2d
Why weight-loss drugs like Ozempic aren’t the long-term solution
Weight-loss drugs like Ozempic and Wegovy are gaining popularity as quick fixes for shedding pounds. Known as GLP-1 agonists, ...